We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-3.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$117B
AUM Growth
-$71.4B
(-38%)
Cap. Flow
-$63.6B
Cap. Flow
% of AUM
-54.42%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
4,580
New
101
Increased
1,974
Reduced
1,229
Closed
1,024
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$190M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$150M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$136M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$306M |
| 2 |
Linde
LIN
|
+$290M |
| 3 |
Principal Financial Group
PFG
|
+$279M |
| 4 |
Evergy
EVRG
|
+$277M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.91% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 13.61% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
3251
DELISTED
DermTech, Inc. Common Stock
DMTK
| $181K | ﹤0.01% |
12,336
-94,989
| -89% | -$1.27M |
|
3252
Oramed Pharmaceuticals
ORMP
$179M
| $180K | ﹤0.01% |
20,809
+2,686
| +15% | +$27.5K |
|
3253
Valaris Ltd Warrants
VAL.WS
$667M
| $179K | ﹤0.01% |
20,903
| – | – |
|
|
RPTX
3254
DELISTED
Repare Therapeutics
RPTX
| $175K | ﹤0.01% |
+12,209
| New | +$181K |
|
3255
Compass
COMP
$9.4B
| $174K | ﹤0.01% |
22,057
+1,465
| +7% | +$11.5K |
|
3256
Playboy Inc
PLBY
$141M
| $174K | ﹤0.01% |
13,291
+853
| +7% | +$14.4K |
|
3257
Oportun Financial
OPRT
$372M
| $173K | ﹤0.01% |
12,031
-572
| -5% | -$9.54K |
|
|
CURO
3258
DELISTED
CURO Group Holdings Corp.
CURO
| $173K | ﹤0.01% |
13,220
+2,099
| +19% | +$28.9K |
|
3259
Caribou Biosciences
CRBU
$164M
| $172K | ﹤0.01% |
18,715
+2,252
| +14% | +$23.7K |
|
3260
Caesarstone
CSTE
$79.5M
| $172K | ﹤0.01% |
16,289
-1,326
| -8% | -$15.7K |
|
|
NEWP
3261
New Pacific Metals
NEWP
$1.17B
| $171K | ﹤0.01% |
53,946
+8,708
| +19% | +$26.7K |
|
|
NS
3262
DELISTED
NuStar Energy L.P.
NS
| $171K | ﹤0.01% |
11,882
-211
| -2% | -$3.41K |
|
|
LX
3263
LexinFintech Holdings
LX
$241M
| $170K | ﹤0.01% |
64,726
-99,957
| -61% | -$331K |
|
3264
Alkami Technology
ALKT
$2.11B
| $168K | ﹤0.01% |
11,697
+676
| +6% | +$10.3K |
|
|
MHN
3265
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
| $168K | ﹤0.01% |
14,000
| – | – |
|
|
GTHX
3266
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $168K | ﹤0.01% |
22,129
+744
| +3% | +$7.06K |
|
3267
Wheels Up
UP
$198M
| $167K | ﹤0.01% |
267
+9
| +3% | +$6.5K |
|
|
OCFT
3268
DELISTED
OneConnect Financial Technology
OCFT
| $166K | ﹤0.01% |
11,770
+33
| +0.3% | +$582 |
|
3269
Kodak
KODK
$983M
| $165K | ﹤0.01% |
25,183
+1,651
| +7% | +$7.84K |
|
3270
El Pollo Loco
LOCO
$462M
| $165K | ﹤0.01% |
14,178
-270
| -2% | -$3.48K |
|
|
VAPO
3271
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $165K | ﹤0.01% |
1,478
-5,968
| -80% | -$746K |
|
|
KLRS
3272
Kalaris Therapeutics
KLRS
$96.8M
| $164K | ﹤0.01% |
1,060
+72
| +7% | +$14.4K |
|
|
ALLK
3273
DELISTED
Allakos
ALLK
| $162K | ﹤0.01% |
28,425
+1,538
| +6% | +$9.94K |
|
|
VLDR
3274
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $161K | ﹤0.01% |
62,680
-34,556
| -36% | -$118K |
|
|
AKRO
3275
DELISTED
Akero Therapeutics
AKRO
| $159K | ﹤0.01% |
11,178
+340
| +3% | +$5.95K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2022 Portfolio in Review
As of Q1 2022, Credit Suisse held 4,580 positions worth $117B, down 38% from $188B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $63.6B in Q1 2022, closing 1,024 positions and reducing 1,229 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in AgileThought Inc worth $43.7M.
- Credit Suisse's largest Q1 2022 buy was AgileThought Inc: 9,605,775 shares worth $43.7M.
- Credit Suisse added most to S&P Global in Q1 2022, an estimated $190M increase.
- Credit Suisse's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $306M.
- Credit Suisse fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $240M.
- Credit Suisse's ten largest holdings make up 20% of its $117B portfolio in Q1 2022.
- Credit Suisse opened 101 new positions and closed 1,024 in Q1 2022.
- Credit Suisse's portfolio value fell 38% quarter-over-quarter to $117B.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.